Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 7349603, 11 pages
http://dx.doi.org/10.1155/2016/7349603
Research Article

NEMO-Binding Domain Peptide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting the NF-κB Signaling Pathway

1Department of Respiratory Medicine, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, China
2Department of Pulmonary Medicine, Chenzhou No. 1 People’s Hospital, Chenzhou, Hunan, China
3Department of Medical Intensive Care Unit, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong, China
4Guangdong Provincial Key Laboratory of Geriatric Infection and Organ Function Support, Guangzhou, Guangdong, China

Received 11 July 2016; Revised 5 September 2016; Accepted 15 September 2016

Academic Editor: Yutong Zhao

Copyright © 2016 Jianhua Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. Rubenfeld, E. Caldwell, E. Peabody et al., “Incidence and outcomes of acute lung injury,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1685–1693, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. G. D. Rubenfeld and M. S. Herridge, “Epidemiology and outcomes of acute lung injury,” Chest, vol. 131, no. 2, pp. 554–562, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Matthay, L. B. Ware, and G. A. Zimmerman, “The acute respiratory distress syndrome,” The Journal of Clinical Investigation, vol. 122, no. 8, pp. 2731–2740, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Putensen, “Acute respiratory distress syndrome (ARDS),” in Sepsis und MODS, pp. 153–166, Springer, Berlin, Germany, 2015. View at Google Scholar
  5. A. M. Modrykamien and P. Gupta, “The acute respiratory distress syndrome,” Proceedings (Baylor University. Medical Center), vol. 28, no. 2, pp. 163–171, 2015. View at Google Scholar
  6. E. Abraham, “Neutrophils and acute lung injury,” Critical Care Medicine, vol. 31, no. 4, pp. S195–S199, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. V. M. Ranieri, G. D. Rubenfeld, B. T. Thompson et al., “Acute respiratory distress syndrome: the Berlin Definition. The ARDS Definition Task Force,” The Journal of the American Medical Association, vol. 307, no. 23, pp. 2526–2533, 2012. View at Publisher · View at Google Scholar
  8. G. Matute-Bello, C. W. Frevert, and T. R. Martin, “Animal models of acute lung injury,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 295, no. 3, pp. L379–L399, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Grommes and O. Soehnlein, “Contribution of neutrophils to acute lung injury,” Molecular Medicine, vol. 17, no. 3-4, pp. 293–307, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Puneet, S. Moochhala, and M. Bhatia, “Chemokines in acute respiratory distress syndrome,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 288, no. 1, pp. L3–L15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. G. He, C. Dong, Z. Luan et al., “Oxygen free radical involvement in acute lung injury induced by H5N1 virus in mice,” Influenza and Other Respiratory Viruses, vol. 7, no. 6, pp. 945–953, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Liu, G. Feng, G.-L. Wang, and G.-J. Liu, “p38MAPK inhibition attenuates LPS-induced acute lung injury involvement of NF-κB pathway,” European Journal of Pharmacology, vol. 584, no. 1, pp. 159–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. S. Hayden and S. Ghosh, “Regulation of NF-κB by TNF family cytokines,” Seminars in Immunology, vol. 26, no. 3, pp. 253–266, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Gerondakis, T. S. Fulford, N. L. Messina, and R. J. Grumont, “NF-κB control of T cell development,” Nature Immunology, vol. 15, no. 1, pp. 15–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nenci, C. Becker, A. Wullaert et al., “Epithelial NEMO links innate immunity to chronic intestinal inflammation,” Nature, vol. 446, no. 7135, pp. 557–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. May, F. D'Acquisto, L. A. Madge, J. Glockner, J. S. Pober, and S. Ghosh, “Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex,” Science, vol. 289, no. 5484, pp. 1550–1554, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. DiDonato, F. Mercurio, and M. Karin, “NF-κB and the link between inflammation and cancer,” Immunological Reviews, vol. 246, no. 1, pp. 379–400, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. J. Szarka, N. Wang, L. Gordon, P. N. Nation, and R. H. Smith, “A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation,” Journal of Immunological Methods, vol. 202, no. 1, pp. 49–57, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Bhatia, R. L. Zemans, and S. Jeyaseelan, “Role of chemokines in the pathogenesis of acute lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 46, no. 5, pp. 566–572, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Dolinay, Y. S. Kim, J. Howrylak et al., “Inflammasome-regulated cytokines are critical mediators of acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 11, pp. 1225–1234, 2012. View at Google Scholar
  21. T. Zhu, D.-X. Wang, W. Zhang et al., “Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-κB,” PLoS ONE, vol. 8, no. 2, Article ID e56407, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. D. P. Schuster, “ARDS: clinical lessons from the oleic acid model of acute lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 149, no. 1, pp. 245–260, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Bhattacharya and M. A. Matthay, “Regulation and repair of the alveolar-capillary barrier in acute lung injury,” Annual Review of Physiology, vol. 75, pp. 593–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Herold, N. M. Gabrielli, and I. Vadász, “Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 305, no. 10, pp. L665–L681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-P. Lee, Y.-C. Li, H.-Y. Chen et al., “Protective effects of luteolin against lipopolysaccharide-induced acute lung injury involves inhibition of MEK/ERK and PI3K/Akt pathways in neutrophils,” Acta Pharmacologica Sinica, vol. 31, no. 7, pp. 831–838, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. B. Ware, “Pathophysiology of acute lung injury and the acute respiratory distress syndrome,” in Proceedings of the Seminars in Respiratory and Critical Care Medicine, pp. 337–349, Thieme Medical, New York, NY, USA, 2006.
  27. C. Basak, S. K. Pathak, A. Bhattacharyya, D. Mandal, S. Pathak, and M. Kundu, “NF-κB- and C/EBPβ-driven interleukin-1β gene expression and PAK1-mediated caspase-1 activation play essential roles in interleukin-1β release from Helicobacter pylori lipopolysaccharide-stimulated macrophages,” The Journal of Biological Chemistry, vol. 280, no. 6, pp. 4279–4288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Wang, Y.-T. Liu, L. Xiao, L. Zhu, Q. Wang, and T. Yan, “Anti-inflammatory effects of apigenin in lipopolysaccharide-induced inflammatory in acute lung injury by suppressing COX-2 and NF-κB pathway,” Inflammation, vol. 37, no. 6, pp. 2085–2090, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Wei and Z. Huang, “Anti-inflammatory effects of triptolide in LPS-induced acute lung injury in mice,” Inflammation, vol. 37, no. 4, pp. 1307–1316, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Wu, G. Zhao, K. Jiang et al., “Plantamajoside ameliorates lipopolysaccharide-induced acute lung injury via suppressing NF-κB and MAPK activation,” International Immunopharmacology, vol. 35, pp. 315–322, 2016. View at Publisher · View at Google Scholar
  31. C. Liu, J. Huang, H. Li et al., “Ghrelin accelerates wound healing through GHS-R1a-mediated MAPK-NF-κB/GR signaling pathways in combined radiation and burn injury in rats,” Scientific Reports, vol. 6, Article ID 27499, 2016. View at Publisher · View at Google Scholar
  32. H. Lv, Z. Yu, Y. Zheng et al., “Isovitexin exerts anti-inflammatory and anti-oxidant activities on lipopolysaccharide-induced acute lung injury by inhibiting MAPK and NF-κB and activating HO-1/Nrf2 pathways,” International Journal of Biological Sciences, vol. 12, no. 1, pp. 72–86, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Schuh and A. Pahl, “Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury,” Biochemical Pharmacology, vol. 77, no. 12, pp. 1827–1834, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. W. Shen, J. Gan, S. Xu, G. Jiang, and H. Wu, “Penehyclidine hydrochloride attenuates LPS-induced acute lung injury involvement of NF-κB pathway,” Pharmacological Research, vol. 60, no. 4, pp. 296–302, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Borregaard, O. E. Sørensen, and K. Theilgaard-Mönch, “Neutrophil granules: a library of innate immunity proteins,” Trends in Immunology, vol. 28, no. 8, pp. 340–345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Del Rio, A. J. Stewart, and N. Pellegrini, “A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 15, no. 4, pp. 316–328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Ueda, M. E. Starr, H. Takahashi et al., “Decreased pulmonary extracellular superoxide dismutase during systemic inflammation,” Free Radical Biology and Medicine, vol. 45, no. 6, pp. 897–904, 2008. View at Publisher · View at Google Scholar · View at Scopus